{"count": 3, "results": [{"_id": "36278239", "pmid": 36278239, "pmcid": "PMC9585190", "title": "Effects of metformin on Sonic hedgehog subgroup medulloblastoma progression: In vitro and in vivo studies", "journal": "Front Pharmacol", "authors": ["Fang H", "Wang L", "Yu L", "Shen F", "Yang Z", "Yang Y", "Li S", "Dai H", "Tan F", "Lin J", "Sheng H"], "date": "2022-10-07T00:00:00Z", "doi": "10.3389/fphar.2022.928853", "meta_date_publication": "2022", "meta_volume": "13", "meta_issue": "", "meta_pages": "928853", "score": 50267.3, "text_hl": "Effects of @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ on @GENE_SHH @GENE_6469 @@@Sonic hedgehog@@@ subgroup @<m>DISEASE_Medulloblastoma</m> @DISEASE_MESH:D008527 @@@medulloblastoma@@@ progression: In vitro and in vivo studies", "citations": {"NLM": "Fang H, Wang L, Yu L, Shen F, Yang Z, Yang Y, Li S, Dai H, Tan F, Lin J, Sheng H. Effects of metformin on Sonic hedgehog subgroup medulloblastoma progression: In vitro and in vivo studies Front Pharmacol. 2022;13():928853. PMID: 36278239", "BibTeX": "@article{36278239, title={Effects of metformin on Sonic hedgehog subgroup medulloblastoma progression: In vitro and in vivo studies}, author={Fang H and Wang L and Yu L and Shen F and Yang Z and Yang Y and Li S and Dai H and Tan F and Lin J and Sheng H}, journal={Front Pharmacol}, volume={13}, pages={928853}}"}}, {"_id": "34124601", "pmid": 34124601, "pmcid": "PMC8171304", "title": "Activation of AMPK sensitizes medulloblastoma to Vismodegib and overcomes Vismodegib-resistance", "journal": "FASEB Bioadv", "authors": ["Gampala S", "Zhang G", "Chang CJ", "Yang JY"], "date": "2021-03-17T00:00:00Z", "doi": "10.1096/fba.2020-00032", "meta_date_publication": "2021 Jun", "meta_volume": "3", "meta_issue": "6", "meta_pages": "459-469", "score": 50258.793, "text_hl": "Next, we tested whether combination of @CHEMICAL_HhAntag691 @CHEMICAL_MESH:C538724 @@@Vismodegib@@@ and @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Metformin@@@ suppresses @GENE_SMO @GENE_6608 @@@SMO@@@ mutant @<m>DISEASE_Medulloblastoma</m> @DISEASE_MESH:D008527 @@@MB@@@ cell lines. ", "citations": {"NLM": "Gampala S, Zhang G, Chang CJ, Yang JY. Activation of AMPK sensitizes medulloblastoma to Vismodegib and overcomes Vismodegib-resistance FASEB Bioadv. 2021 Jun;3(6):459-469. PMID: 34124601", "BibTeX": "@article{34124601, title={Activation of AMPK sensitizes medulloblastoma to Vismodegib and overcomes Vismodegib-resistance}, author={Gampala S and Zhang G and Chang CJ and Yang JY}, journal={FASEB Bioadv}, volume={3}, number={6}, pages={459-469}}"}}, {"_id": "37905067", "pmid": 37905067, "title": "HIF-1 inactivation empowers HIF-2 to drive hypoxia adaptation in aggressive forms of medulloblastoma.", "journal": "bioRxiv", "authors": ["Contenti J", "Guo Y", "Larcher M", "Mirabal-Ortega L", "Rouleau M", "Irondelle M", "Tiroille V", "Mazzu A", "Duranton-Tanneur V", "Pedeutour F", "Ben-Sahra I", "Lago C", "Leva G", "Tiberi L", "Robert G", "Pouponnot C", "Bost F", "Mazure NM"], "date": "2023-10-20T00:00:00Z", "doi": "10.1101/2023.10.17.562750", "meta_date_publication": "2023 Oct 20", "meta_volume": "", "meta_issue": "", "meta_pages": "", "score": 50250.707, "text_hl": "By combining pharmacological inhibition of @GENE_EPAS1 @GENE_2034 @@@HIF-2alpha@@@ with the use of @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@, a mitochondrial complex I inhibitor to block respiration, we effectively induced Group @<m>DISEASE_Medulloblastoma</m> @DISEASE_MESH:D008527 @@@3 MB@@@ cell death, surpassing the effectiveness observed in Non-Group @<m>DISEASE_Medulloblastoma</m> @DISEASE_MESH:D008527 @@@3 MB@@@ cells. ", "citations": {"NLM": "Contenti J, Guo Y, Larcher M, Mirabal-Ortega L, Rouleau M, Irondelle M, Tiroille V, Mazzu A, Duranton-Tanneur V, Pedeutour F, Ben-Sahra I, Lago C, Leva G, Tiberi L, Robert G, Pouponnot C, Bost F, Mazure NM. HIF-1 inactivation empowers HIF-2 to drive hypoxia adaptation in aggressive forms of medulloblastoma. bioRxiv. 2023 Oct 20;():. PMID: 37905067", "BibTeX": "@article{37905067, title={HIF-1 inactivation empowers HIF-2 to drive hypoxia adaptation in aggressive forms of medulloblastoma.}, author={Contenti J and Guo Y and Larcher M and Mirabal-Ortega L and Rouleau M and Irondelle M and Tiroille V and Mazzu A and Duranton-Tanneur V and Pedeutour F and Ben-Sahra I and Lago C and Leva G and Tiberi L and Robert G and Pouponnot C and Bost F and Mazure NM}, journal={bioRxiv}}"}}]}